BETWEENAsset Purchase Agreement • February 11th, 2004 • Barr Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
Table of Contents ----------------- (continued) Page ---- 3.30 Regulatory Compliance...............................................22 3.31 Conduct of Business Since Most Recent Balance Sheet Date............23 3.32 Broker's or Consultant's...Asset Purchase Agreement • August 26th, 2002 • Barr Laboratories Inc • Pharmaceutical preparations • New York
EXECUTION VERSION [Published CUSIP Number: ____________] CREDIT AGREEMENT Dated as of July 21, 2006Credit Agreement • July 26th, 2006 • Barr Pharmaceuticals Inc • Pharmaceutical preparations • New York
UNDERWRITING AGREEMENTUnderwriting Agreement • September 14th, 2000 • Barr Laboratories Inc • Pharmaceutical preparations • New York
LEASE FROM:Lease • April 25th, 2003 • Barr Laboratories Inc • Pharmaceutical preparations • New Jersey
WITNESSETH:Employment Agreement • November 6th, 2003 • Barr Laboratories Inc • Pharmaceutical preparations
UNDERWRITING AGREEMENT , 1998Underwriting Agreement • January 30th, 1998 • Barr Laboratories Inc • Pharmaceutical preparations • New York
WITNESSETH:Agreement • November 6th, 2003 • Barr Laboratories Inc • Pharmaceutical preparations • New York
AmongAgreement and Plan of Merger • May 3rd, 2004 • Barr Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
Exhibit 2.1 AGREEMENT AND PLAN OF MERGER THIS AGREEMENT AND PLAN OF MERGER (this "Agreement") is effective as of December 31, 2003, by and between Barr Laboratories, Inc., a New York corporation ("Barr-NY" or the "Non-Surviving Company"), and Barr...Agreement and Plan of Merger • January 6th, 2004 • Barr Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
WITNESSETH:Employment Agreement • August 26th, 2002 • Barr Laboratories Inc • Pharmaceutical preparations • New York
WITNESSETH:Employment Agreement • August 26th, 2002 • Barr Laboratories Inc • Pharmaceutical preparations
WITNESSETH:Employment Agreement • August 24th, 2001 • Barr Laboratories Inc • Pharmaceutical preparations • New York
EXHIBIT 10.15Development and Marketing Agreement • May 2nd, 2000 • Barr Laboratories Inc • Pharmaceutical preparations • New York
WITNESSETH:Employment Agreement • August 26th, 2002 • Barr Laboratories Inc • Pharmaceutical preparations
CREDIT AGREEMENT Dated as of August 30, 2004 among BARR PHARMACEUTICALS, INC., as the Borrower, BANK OF AMERICA, N.A., as Administrative Agent, Swing Line Lender and L/C Issuer, JPMORGAN CHASE BANK, as Syndication Agent, and The Other Lenders Party...Credit Agreement • November 5th, 2004 • Barr Pharmaceuticals Inc • Pharmaceutical preparations • New York
This CREDIT AGREEMENT (“Agreement”) is entered into as of August 30, 2004, among Barr Pharmaceuticals, Inc., a Delaware corporation (the “Borrower”), certain of the Subsidiaries of the Borrower (individually a “Guarantor” and collectively the “Guarantors”), each lender from time to time party hereto (collectively, the “Lenders” and individually, a “Lender”). JPMORGAN CHASE BANK, as syndication agent (the “Syndication Agent”), and BANK OF AMERICA, N.A., as Administrative Agent, Swing Line Lender and L/C Issuer.
AMENDMENT TO THE EMPLOYMENT AGREEMENTEmployment Agreement • November 21st, 2008 • Barr Pharmaceuticals Inc • Pharmaceutical preparations • New York
THIS AMENDMENT TO EMPLOYMENT AGREEMENT (the “Amendment”) is entered into as of November 18, 2008 by and between Barr Pharmaceuticals, Inc., a Delaware corporation having its principal executive offices at 225 Summit Avenue, Montvale, New Jersey 07645-1523 (the “Company”), and Jane F. Greenman (the “Employee”).
AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • August 7th, 2008 • Barr Pharmaceuticals Inc • Pharmaceutical preparations • New York
This AMENDED AND RESTATED EMPLOYMENT AGREEMENT (this “Agreement”) dated as of the 15th day of July 2008, between Barr Pharmaceuticals, Inc., a Delaware corporation having its principal executive offices at 225 Summit Avenue, Montvale, New Jersey 07645-1523 (the “Company”), and Sigurd Kirk (the “Employee”).
2 3 (iv) Restriction on Transfer, Proxies and Non-Interference. Except as otherwise contemplated by the Merger Agreement or this Agreement, from and after the date of this Agreement and ending on the first to occur of the Effective Time or the...Parent Stockholder Voting Agreement • August 7th, 2001 • Barr Laboratories Inc • Pharmaceutical preparations • Delaware
3 4 under this Agreement and to consummate the transactions contemplated hereby. This Agreement has been duly and validly executed and delivered by Parent and (assuming this Agreement is duly and validly executed and delivered by the other signatories...Company Stockholders Voting Agreement • August 7th, 2001 • Barr Laboratories Inc • Pharmaceutical preparations • Delaware
AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • October 10th, 2006 • Barr Pharmaceuticals Inc • Pharmaceutical preparations
AGREEMENT dated as of the 19th day of August, 2005 between Barr Pharmaceuticals, Inc. (“BPI”) and Barr Laboratories, Inc. (“BLI-DE”), Delaware corporations having their principal executive offices at 400 Chestnut Ridge Road, Woodcliff Lake, New Jersey 07677, and Duramed Research Inc., a Delaware corporation having its principal executive offices at 1 Belmont Avenue, Bala Cynwd, PA 19004 (“DRI”), parties of the first part, and Carole Ben-Maimon (the “Employee”).
CREDIT AGREEMENT Dated as of June 19, 2008 among BARR LABORATORIES, INC., as Borrower, and BARR PHARMACEUTICALS, INC., and CERTAIN SUBSIDIARIES FROM TIME TO TIME PARTY HERETO, as Guarantors BANK OF AMERICA, N.A., as Administrative Agent, and The Other...Credit Agreement • June 23rd, 2008 • Barr Pharmaceuticals Inc • Pharmaceutical preparations • New York
This CREDIT AGREEMENT (“Agreement”) is entered into as of June 19, 2008, among Barr Laboratories, Inc., a Delaware corporation (the “Borrower”), Barr Pharmaceuticals, Inc., a Delaware corporation (the “Parent”) as a guarantor along with certain Subsidiaries of the Parent (individually a “Guarantor” and collectively the “Guarantors”), each lender from time to time party hereto (collectively, the “Lenders” and individually, a “Lender”), and Bank of America, N.A., as Administrative Agent.
AGREEMENT AND PLAN OF MERGER by and among BARR PHARMACEUTICALS, INC., TEVA PHARMACEUTICAL INDUSTRIES LTD. and BORON ACQUISITION CORP. Dated as of July 17, 2008Agreement and Plan of Merger • July 18th, 2008 • Barr Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
AGREEMENT AND PLAN OF MERGER (hereinafter called this “Agreement”), dated as of July 17, 2008, by and among Barr Pharmaceuticals, Inc., a Delaware corporation (the “Company”), Teva Pharmaceutical Industries Ltd., an Israeli corporation (“Parent”), and Boron Acquisition Corp., a Delaware corporation and a wholly owned direct subsidiary of Parent (“Merger Sub”).
AMENDMENT OF EMPLOYMENT AGREEMENTEmployment Agreement • March 20th, 2006 • Barr Pharmaceuticals Inc • Pharmaceutical preparations
AMENDMENT dated the 13th day of March, 2006, of the Amended and Restated Employment Agreement dated March 13, 2006 between Barr Pharmaceuticals, Inc. (“BPI”) and Barr Laboratories, Inc. (“BLI-DE”), Delaware corporations having their principal executive offices at 400 Chestnut Ridge Road, Woodcliff Lake, New Jersey 07677, parties of the first part, and Paul Bisaro (the “Employee”).
SECOND AMENDMENT TO CREDIT AGREEMENTCredit Agreement • October 29th, 2008 • Barr Pharmaceuticals Inc • Pharmaceutical preparations
THIS SECOND AMENDMENT TO CREDIT AGREEMENT (this “Amendment”), dated as of October 27, 2008, is by and among BARR LABORATORIES, INC., a Delaware corporation (the “Company”), certain Foreign Subsidiaries of the Company party hereto pursuant to Section 2.14 of the hereinafter defined Existing Credit Agreement (each a “Designated Foreign Borrower”; and together with the Company, the “Borrowers” and, each a “Borrower”), Barr Pharmaceuticals, Inc., a Delaware corporation (the “Parent”) as a guarantor along with certain Subsidiaries of the Parent (individually a “Guarantor” and collectively the “Guarantors”), the Lenders party hereto (collectively, the “Lenders” and individually, a “Lender”), and BANK OF AMERICA, N.A., as Administrative Agent for the Lenders (the “Administrative Agent”) and as Swing Line Lender and L/C Issuer. Terms used but not otherwise defined herein shall have the meanings provided in the Existing Credit Agreement described below.
ContractBarr Pharmaceuticals Inc • August 15th, 2006 • Pharmaceutical preparations
Barr and Shire Sign Three Agreements: A Product Acquisition Agreement for ADDERALL®; A Product Development Agreement; and A Settlement and License Agreement for ADDERALL XR®
Amendment of Bruce Downey’s Employment Agreement dated March 13, 2006 (“Employment Agreement”)Employment Agreement • February 29th, 2008 • Barr Pharmaceuticals Inc • Pharmaceutical preparations
FIRST AMENDMENT TO CREDIT AGREEMENTCredit Agreement • October 29th, 2008 • Barr Pharmaceuticals Inc • Pharmaceutical preparations
THIS FIRST AMENDMENT TO CREDIT AGREEMENT (this “Amendment”), dated as of October 27, 2008, is by and among BARR LABORATORIES, INC., a Delaware corporation (the “Borrower”), Barr Pharmaceuticals, Inc., a Delaware corporation (the “Parent”) as a guarantor along with certain Subsidiaries of the Parent (individually a “Guarantor’’ and collectively the “Guarantors”), the Lenders party hereto (collectively, the “Lenders” and individually, a “Lender”), and BANK OF AMERICA, N.A., as Administrative Agent for the Lenders (the “Administrative Agent”). Terms used but not otherwise defined herein shall have the meanings provided in the Existing Credit Agreement described below.
Barr Pharmaceuticals, Inc.Letter Agreement • October 10th, 2006 • Barr Pharmaceuticals Inc • Pharmaceutical preparations
This letter agreement (the “Letter Agreement”) sets forth certain amendments to the employment agreement between you and Barr Pharmaceuticals, Inc. (“BPI”), Barr Laboratories, Inc. and Duramed Research Inc. dated as of August 19, 2005 (the “Employment Agreement”). If you agree to these amendments and the other provisions set forth below in this Letter Agreement, and that they are supported by valuable consideration which you have received and will receive, please sign this Letter Agreement where indicated below and return it to me, whereupon it will become immediately binding upon you and the other signatories to the Employment Agreement. The duplicate is for your files.
Urdang/IPA Montvale, LLC c/o Ivy Realty Services, LLC One Paragon Drive Suite 125 Montvale, New Jersey 07645Guaranty of Lease • November 6th, 2008 • Barr Pharmaceuticals Inc • Pharmaceutical preparations • New Jersey
Reference is made to that certain Lease dated April 23, 2007, between Urdang/IPA Montvale, LLC, as lessor (“Lessor”), and Barr Laboratories, Inc., as lessee (“Lessee”), for certain premises located at 225 Summit Avenue, Montvale, New Jersey, as amended by Letter Agreement dated May 10, 2007 and Letter Agreement dated May 15, 2008 (collectively, “Lease”). Any capitalized terms not defined in this letter agreement (“Letter Agreement”) shall have the meanings as set forth in the Lease.
Release of ClaimsRelease of Claims • October 10th, 2006 • Barr Pharmaceuticals Inc • Pharmaceutical preparations
In consideration of the $1.5 million Severance Benefit to be paid to me pursuant to section 5 of the employment agreement between me and Barr Pharmaceuticals, Inc., Barr Laboratories, Inc. and Duramed Research Inc. dated as of August 19, 2005 as amended by a letter agreement dated August 28, 2006 (the “Employment Agreement”), I hereby agree as follows:
PRODUCT DEVELOPMENT AND LICENSE AGREEMENT BY AND BETWEEN SHIRE LLC AND DURAMED PHARMACEUTICALS, INC. DATED AS OF AUGUST 14, 2006Supply Agreement • November 9th, 2006 • Barr Pharmaceuticals Inc • Pharmaceutical preparations • New York
This PRODUCT DEVELOPMENT AND LICENSE AGREEMENT (the “Agreement”) is dated as of August 14, 2006 by and among SHIRE LLC, a Kentucky limited liability company having a principal place of business at 9200 Brookfield Court, Florence, Kentucky 41042 (together with its Affiliates, “Shire”), SHIRE plc, a British public limited company having a principal place of business at Hampshire International Business Park, Chineham, Basingstoke, England RG24 8EP, solely for purposes of the provisions of Section 15.10 of this Agreement, and DURAMED PHARMACEUTICALS, INC., a Delaware corporation having a place of business at 400 Chestnut Ridge Road, Woodcliff Lake, NJ 07677 (“Duramed”). Shire and Duramed are sometimes referred to herein individually as a “Party” and together as the “Parties”.
Dated 21 March 2007 PLIVA d.d. and Željko Čović AGREEMENT WITH THE PRESIDENT OF THE MANAGEMENT BOARD AND COOAgreement • May 10th, 2007 • Barr Pharmaceuticals Inc • Pharmaceutical preparations
Exhibit 10.25 EMPLOYMENT AGREEMENT AGREEMENT dated as of the 7th day of February, 2001 between Barr Laboratories, Inc., a New York corporation having its principal executive offices at 300 Corporate Drive, Building #10, Bradley Corporate Park,...Employment Agreement • August 26th, 2002 • Barr Laboratories Inc • Pharmaceutical preparations • New York
ARTICLE I Definitions SECTION 1.01. Definitions. The following terms shall have the following meanings: "Adjustment Date" shall mean the date that is six months prior to the Final Expiration Date. "*** Settlement Agreement" shall have the meaning set...Execution Copy Supply Agreement • May 14th, 1997 • Barr Laboratories Inc • Pharmaceutical preparations • New York
